ASHLEY KNAVEL: Open Payments
NPI 1861833824 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$822 in 47 payments from 12 companies in 2025. Trend: 2023 $41 · 2024 $145 · 2025 $822
Food & beverage: $822
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $208 |
| UCB, Inc. | 5 | $185 |
| Incyte Corporation | 11 | $138 |
| GENZYME CORPORATION | 3 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Organon LLC | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Janssen Biotech, Inc. | 1 | $24 |
| LEO Pharma Inc. | 1 | $22 |
| Amgen Inc. | 1 | $21 |
Products named: SKYRIZI, Bimzelx, OPZELURA, DUPIXENT, Rhapsido, TREMFYA, ADBRY, OTEZLA.
Industry payments across NY — which companies pay providers there.
